Cargando…
A novel design for randomized immuno-oncology clinical trials with potentially delayed treatment effects
The semi-parametric proportional hazards model is widely adopted in randomized clinical trials with time-to-event outcomes, and the log-rank test is frequently used to detect a potential treatment effect. Immuno-oncology therapies pose unique challenges to the design of a trial as the treatment effe...
Autores principales: | He, Pei, Su, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935831/ https://www.ncbi.nlm.nih.gov/pubmed/29736436 http://dx.doi.org/10.1016/j.conctc.2015.08.003 |
Ejemplares similares
-
Master protocols in immuno-oncology: do novel drugs deserve novel designs?
por: Mazzarella, Luca, et al.
Publicado: (2020) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017) -
Novel strategies for immuno-oncology breakthroughs with cell therapy
por: Liu, Hongtao, et al.
Publicado: (2021) -
Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019) -
Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)